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Background: Spinal cord ischemia (SCI) remains a significant concern in patients undergoing endovascular repair
involving the thoracic aorta (thoracic endovascular aortic repair [TEVAR]). Perioperative lumbar spinal drainage has
been widely practiced for open repair, but there is no consensus treatment protocol using lumbar drainage for SCI
associated with TEVAR. This study analyzes the efficacy of an institutional protocol using selective lumbar drainage
reserved for patients experiencing SCI following TEVAR.
Methods: A prospectively maintained registry was reviewed to identify all patients who underwent TEVAR from January
2000 through June 2010. Preoperative characteristics, intraoperative details, and outcomes, including neurologic deficit
and mortality at 30 days and 1 year were determined based on reporting standards. Patients developing symptoms of SCI
in the postoperative setting were compared with those without neurologic symptoms. SCI patients who received selective
lumbar drainage were grouped based on resolution of neurologic function, with risk factors and outcomes of these
subgroups analyzed with 2, t test, logistic regression, and analysis of variance (ANOVA).
Results: Two hundred seventy-eight TEVARs were performed on 251 patients. Twelve patients accounting for 12
TEVARs were excluded from analysis: 5 patients experienced SCI preoperatively, 4 patients were drained preoperatively,
2 expired intraoperatively, and 1 procedure was aborted. Of the remaining 266 procedures in 239 patients, 16 (6.0%)
developed SCI within the 30-day postoperative period. Risk factors for SCI reaching statistical significance included
length of aortic coverage (P .036), existence of infrarenal aortic pathology (P .026), and history of stroke (P .043).
Stent graft coverage of the left subclavian artery origin was required in 28.9% (n  77) and was not associated with SCI
(P .52). Ten of 16 post-TEVAR SCI patients received selective postoperative lumbar drains and were categorized based
on resolution of symptoms into complete resolution (n 3; 30%), partial resolution (n 4; 40%), and no resolution (n
3; 30%). No patient characteristics or risk factors reached significance in comparison of lumbar drained patients and
nondrained patients. All seven drained patients without complete resolution of SCI died within the first year after
surgery, while all three of the complete responders survived (P .017). In patients with SCI, increased all-cause mortality
was observed at 1 year (56.3% vs 20.4%; P  .003).
Conclusions: A protocol utilizing selective postoperative lumbar spinal drainage can be used safely for patients developing
SCI after TEVAR with acceptably low permanent neurologic deficit, although overall survival of patients experiencing
SCI after TEVAR is diminished relative to non-SCI patients. ( J Vasc Surg 2012;55:1-9.)
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fSpinal cord ischemia (SCI) associated with repair of
thoracic aortic pathology is of significant concern. Re-
ported rates of SCI with open repair of thoracoabdominal
aortic aneurysms (TAA) range from 2% to 21%.1-3 Al-
though the risk of SCI has not been completely established
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doi:10.1016/j.jvs.2011.07.086or thoracic endovascular aneurysm repair (TEVAR), re-
orted rates trend lower in comparison to open repair,
anging from 3% to 12%.1-8 TEVAR’s avoidance of physi-
logic insults due to prolonged aortic cross clamping used
n open thoracoabdominal aortic aneurysm (TAAA) repair
ay lead to more favorable outcomes.
While spinal cord protective protocols are widely used
ith open TAAA repair, these measures are less defined for
EVAR. Some have suggested a prophylactic approach by
nitiating routine spinal drainage preoperatively while oth-
rs have advocated postoperative drainage only in those
atients experiencing neurologic deficits indicative of SCI
n the postoperative setting.4,9-11 Our institutional prefer-
nce is for selective lumbar spinal drainage and increased
ean arterial pressure (MAP) to improve spinal cord per-
usion for patients developing neurologic deficit from SCI
fter TEVAR. The purpose of this study is to evaluate the
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January 20122 Keith et alrisk of SCI in patients undergoing TEVAR and determine
the efficacy of selective postoperative lumbar drainage in
reversing symptoms of SCI.
METHODS
A prospectively maintained computerized vascular reg-
istry was reviewed to identify all patients who underwent
TEVAR from January 2000 through June 2010. Patient
records were reviewed for preoperative, intraoperative, and
postoperative characteristics based on reporting stan-
dards.12 Demographic data included gender, race, and age
at the time of operation. Medical histories were reviewed
for presence of hypertension, coronary artery disease
(CAD), coronary artery bypass grafting (CABG), percuta-
neous transluminal coronary angioplasty (PTCA), stroke,
diabetes mellitus (DM), chronic obstructive pulmonary
disease (COPD), hyperlipidemia, smoking (current/previ-
ous or never), and renal disease. Preoperative factors in-
cluded thoracic aorta pathology (aneurysm, dissection,
trauma, rupture, mycotic, and pseudoaneurysm), previous
or concomitant infrarenal aortoiliac pathology (aneurysm,
dissection, prior endovascular repair, prior open repair, iliac
disease, including decreased patency and aneurismal pa-
thology as a single variable, multiple, or none), mean
arterial pressure, and operative timing (elective or urgent/
emergent defined as surgical intervention within 48 hours
of presentation). Intraoperative factors, including total
length of aortic coverage by endograft(s), left subclavian
artery origin coverage (no coverage with no reconstruction,
no coverage with reconstruction, coverage with prior re-
construction, coverage with reconstruction performed in
the same operation, coverage with continued antegrade
blood flow into the artery, and other which included intra-
operative death and inability to evaluate), inflow to the
endograft (from the thoracic aorta or from a previously
placed graft), outflow from the endograft (into the thoracic
aorta, suprarenal abdominal aorta, infrarenal abdominal
aorta, or a previous graft), and presence of an endoleak at
the conclusion of the procedure were recorded. Intraoper-
ative measurements of stent graft coverage were made with
the assistance of intraoperative angiogram with intralumi-
nal marker catheters and intravascular ultrasound, and were
correlated with preoperative computed tomography (CT)
angiograms. Postoperative factors included symptoms in-
dicative of spinal cord ischemia (any lower extremity weak-
ness or loss of sensation), immediate post-op MAP, hours
spent in the intensive care unit (ICU), postoperative hos-
pital length of stay (days), disposition at discharge (home,
rehabilitation, deceased, reoperation within admission, or
other), endoleak, stent graft patency (primary, assisted, or
occluded), and 30-day and 1-year mortality.
Our institutional preference for selective lumbar drain-
age and increased MAP reserved for those developing SCI
after TEVAR has been practiced since 2000 at University of
Alabama at Birmingham, but it was formalized into a
prospective protocol in 2007 (Fig). Neurologic assessment
occurred in the postoperative setting every 2 hours for an
initial 8 hours, then every 4 hours if no neurologic change bas noted. If a change in neurologic examination pre-
ented, initial measures included patient transfer to the
CU if not already in a monitored unit, increase in fre-
uency of neurologic assessments to every hour, increase in
AP to 110 mm Hg with intravascular volume expand-
rs and pharmacologically, and discontinuation of medica-
ions that could potentially interfere with neurological ex-
minations. If there was less than 4/5 motor function or
ignificant sensory loss, lumbar drain was immediately
laced. For neurologic change with greater than or equal to
/5 motor function or minor sensory loss: an immediate
agnetic resonance imaging (MRI) scan of the thoracic
nd lumbar spine was obtained if clinically feasible to rule
ut other potential causes of the deficit, and if ischemia was
resent, to determine whether or not it was reversible. If
eurologic symptoms resolved within 2 to 3 hours, phar-
acologic treatment was continued along with hemody-
amic and neurologic monitoring at the attending physi-
ian’s discretion. If no improvement was made within the
- to 3-hour interval and MRI indicated a reversible isch-
mia, a lumbar drain was placed.
Lumbar drainage was maintained for no 24 hours
ith a pop-off drainage set at 10 cm of water. Intrathecal
pening pressure and volume of drainage were monitored.
RI was obtained once the patient was hemodynamically
table if one was not obtained prior to lumbar drain place-
ent. Adjustments in the lumbar drainage protocol were
ermissible based upon a fluctuating clinical examination or
igh volume of drainage (150 mL/24 h). The lumbar
rain was discontinued when pressure equilibrated back to
ormal range and/or neurologic examination reached a
lateau.
For statistical analysis, all TEVAR procedures were
ivided into groups with and without subsequent SCI, and
hey were compared to determine significant risk factors for
CI following TEVAR. Categorical variables were analyzed
sing nonparametric chi square test, and continuous vari-
bles were analyzed with Student t test. In instances where
2 test was unreliable due to a small sample size, Fisher
xact method was employed to test the association. Tho-
acic aorta pathology, infrarenal pathology, urgency, and
eft subclavian artery coverage were analyzed as categorical
ariables, while age, length of aortic coverage by endograft,
re- and post-op MAP, post-op hospital days, time to
ymptom onset, and time to drain placement after symp-
om onset were analyzed as continuous variables. Chronic
isease states such as hypertension, coronary artery disease,
OPD, and other previous disease states such as history of
troke were defined by documentation of prior diagnosis by
physician or current use of medications for such diseases.
o determine the strength of association after adjusting for
ll factors, multivariate logistic regression was employed,
ncluding all of the variables that were significantly associ-
ted with SCI in univariate analysis. Following analysis of
isk factors for SCI, we performed a subgroup analysis,
ncluding only those SCI patients who received lumbar
pinal drainage. For these analyses, patients were grouped
ased on the degree of neurologic symptom resolution
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Volume 55, Number 1 Keith et al 3achieved following drainage (complete, partial, none), and
group differences in the continuous variables were tested
using nonparametric analysis of variance (ANOVA) test.
RESULTS
Study population. From January 2000 through June
2010, 278 TEVARs were performed in 251 patients.
Twelve patients accounting for 12 procedures were ex-
cluded from analysis: 5 patients experienced spinal cord
ischemia preoperatively, 4 patients received lumbar spinal
drainage preoperatively due to concern for potential in-
creased risk of SCI, 2 patients expired intraoperatively, and
1 procedure was aborted due to failure of graft deployment.
The remaining 266 procedures in 239 patients constitute
the study population. Mean age was 64.1 14.9 years, and
gender distribution was 62.8% male and 37.2% female.
Treated thoracic aortic pathologies consisted of 147 degen-
erative aneurysm (55.3%), 76 aortic dissection (28.6%), 37
trauma/rupture (13.9%), 4 mycotic aneurysm (1.5%), and
2 pseudoaneurysm (0.8%). One hundred seventeen (44%)
procedures involved concomitant infrarenal aortic or iliac
pathology, and 100 (37.6%) were considered urgent/
emergent. Overall, 17 patients (6.4%) died within 30 days
of the procedure, and 60 (22.6%) died within 1 year.
SCI vs non-SCI. SCI occurred following 16 TEVARs
Fig. Protocol for selective post-op lumbar spinal drain
repair (TEVAR). ICU, Intensive care unit; MAP, mean(6.0%) within the 30-day postoperative period, and com- warison was performed of SCI and non-SCI groups. There
as no significant difference between groups for patient
haracteristics and demographic factors except for prior
troke history (Table I). Five (31.3%) SCI patients had a
istory of stroke compared with 30 (12%) of the non-SCI
atients (P  .044). Other risk factors determined to be
ignificant for SCI were the presence of infrarenal aortic or
liac pathology (P .026) and length of aortic coverage by
ndograft (P  .036) (Table II). Infrarenal aortic or iliac
athologies were present in 12 SCI patients (75%) and in
2% of the non-SCI patients. Patients with a concomitant
nfrarenal aortic aneurysm in particular had seven times
reater odds of developing SCI than patients without in-
rarenal pathology (odds ratio [OR]: 6.6; 95% confidence
nterval [CI]: 1.6-27.9). Mean length of aortic coverage by
ndograft in the SCI group was 28.5  8.5 cm (range
0-45 cm) vs 23.1  10.1 cm (range 4-63 cm) in the
on-SCI group. Thoracic aortic pathology and urgency of
rocedure were not significantly different between the SCI
nd non-SCI groups (P .808; P .291). Coverage of the
eft subclavian artery origin was required in 5 (31.3%)
rocedures resulting in SCI and 72 (28.8%) not resulting in
CI and was not significant (P  .520). Hospital length of
tay reached marginal significance, as SCI patients spent an
verage of 18.6  21.9 days in the hospital postoperation
patients undergoing thoracic endovascular aneurysm
al pressure; MRI, magnetic resonance imaging.age inhile the non-SCI group spent a mean of 10.5  16 days
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January 20124 Keith et al(P  .056) (Table III). Increased all cause mortality at 1
year was observed in SCI patients (56.3% vs 20.4%, P 
.003). Those with SCI had three times greater odds of
dying within 1 year of the procedure than non-SCI patients
(OR: 3.0; 95% CI: 1.0-15.0).
Drained vs not drained. Of the 16 patients experi-
encing SCI postoperatively, 10 were treated via selective
lumbar spinal drainage (Table IV). Three (30%) drained
patients recovered full neurologic function, four (40%)
achieved partial recovery, and three (30%) had no resolu-
tion of symptoms. Mean time of symptom onset was
35.7  48.6 hours postoperation, and mean time from
symptom onset to drain placement was 8.2  10.5 hours.
One patient (10%) with no prior risk factors experienced a
subdural hematoma after lumbar drain placement, but
eventually made a partial neurologic recovery. Within the
group of drained patients, 6 (60%) were discharged to a
rehabilitation facility, 2 (20%) to home, 1 (10%) died prior
to discharge, and 1 (10%) required additional intervention
prior to discharge. Two (20%) drained patients died within
the 30-day postoperative period, and seven (70%) died
within 1 year.
No risk factors were found to be significant in compar-
ison of drained patients by symptom resolution (complete,
partial, and none). The time from symptom onset to drain
placement reached marginal significance between the three
resolution groups (P  .068). The three drained patients
with complete resolution received drains at a mean of 4.0
2.0 hours after symptom onset, the four patients with
partial resolution received drains at a mean of 3.0  1.2
hours, and the three patients with no resolution of symp-
toms received drains at an average of 19.3  15.0 hours.
Table I. Comparison of demographics between patients d
TEVAR (n  266)
SCI
n %
Total 16 6.0
Sex (male) 9 56.3
Race (white) 13 81.3
Hypertension 16 100
CAD 10 62.5
CABG 4 25
PTCA 3 18.8
Stroke 5 31.3
Smoking (current, past) 13 81.3
Diabetes 4 25
Hyperlipidemia 9 56.3
COPD 7 43.8
Renal disease 2 12.5
Creatinine (1.4) 6 37.5
Mean  SD Range Mean 
Age (years) 67.8  8.5 52-83 63.8  1
CABG, Coronary artery bypass grafting; CAD, coronary artery disease; CO
coronary angioplasty; SCI, spinal cord ischemia; SD, standard deviation; TEAdditionally, all 7 patients with incomplete resolution of mymptoms (4 partial and 3 none) died within the first year
fter surgery, while all 3 patients achieving complete reso-
ution of symptoms survived (P  .017).
Six SCI patients did not receive lumbar spinal drainage.
easons for not placing a lumbar drain were as follows: 3
atients who underwentMRI indicating reversible SCI had
omplete symptom resolution with 2 to 3 hours of phar-
acologic treatment, MRI suggested that 1 patient’s
ymptoms were attributed to a vertebral disk pressing the
ord, 1 patient expired via cardiopulmonary collapse in the
rocess of placing a drain, and 1 patient’s symptoms were
reated with vasopressors by neurosurgery following MRI
s a deviation from protocol. Of these six patients, four
66.7%) regained complete lower extremity function while
wo (33.3%) did not have any resolution of symptoms.
ean time of symptom onset was 29.5  18.7 hours
ost-op. For disposition, four patients with complete reso-
ution of symptoms were discharged to home, and two with
o resolution died prior to discharge. Thirty-day mortality
ccurred in one (16.7%) patient, while two (33.3%) died
ithin 1 year. None of the comparisons noted varied sig-
ificantly between the drained and nondrained groups,
lthough sample population was small.
ISCUSSION
The precise mechanism by which SCI arises is not
ompletely understood, although it may relate to reperfu-
ion injury and other hemodynamic derangements. In-
reased length of aortic coverage by endograft is frequently
ssociated with SCI.5,7,8,13,14 With increased coverage of
he aorta comes increased exclusion of intercostals neces-
ary for spinal cord perfusion. TEVAR seemingly poses
ping postoperative SCI and those without SCI after
Non-SCI Total
% P n %
94.0 — 266 100
63.2 .577 167 62.8
70 .410 186 69.9
83.6 .144 225 84.6
40.8 .117 112 42.1
18.4 .512 50 18.8
13.6 .474 37 13.9
12 .044 35 13.2
70.8 .569 190 71.4
21.2 .720 57 21.4
39.6 .200 108 40.6
28.8 .258 79 29.7
4.4 .180 13 4.9
20.4 .119 57 21.4
Range P Mean  SD Range
9-88 .101 64.1  14.9 9-88
chronic obstructive pulmonary disease; PTCA, percutaneous transluminal
thoracic endovascular aneurysm repair.evelo
n
250
158
173
209
102
46
34
30
177
53
99
72
11
51
SD
5.2
PD,ore of a risk than open repair due to the inability to
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an increasing incidence of SCI with longer stent graft
coverage of the thoracic aorta (mean length of coverage for
SCI group was 28.5  8.5 cm vs 23.1  10.1 cm for
non-SCI; P  .036), although there is no length that
absolutely defines the increased risk of SCI. The presence of
infrarenal aortic or iliac disease, or previous repair of such
pathologies, has also been linked to post-TEVAR
SCI,4,5,7,11,14 and our study supports this association (75%
SCI vs 42% non-SCI; P .026). However, coverage of the
origin of the left subclavian artery has been linked to
SCI,3,15,16 but this was not observed in this study (31.3%
SCI required coverage vs 30.8% non-SCI; P  .520).
Perioperative hypotension, defined as MAP 70-mm Hg,
Table II. Comparison of thoracic aortic factors between p
after TEVAR (n  266)
SCI
n %
Thoracic aorta pathology
Aneurysm 8 50
Dissection 5 31.3
Trauma/rupture 3 18.8
Mycotic 0 0
Pseudoaneurysm 0 0
Infrarenal pathology
Aneurysm 6 37.5
Dissection 1 6.3
Open repair 3 18.8
Endo repair 0 0
Iliac disease 1 6.3
Multiple 1 6.3
None 4 25
Urgency
Elective 8 50
Urgent/emergent 8 50
L subclavian coverage
Not covered
No reconstruction 11 68.8
Reconstruction 0 0
Covered
No reconstruction 1 6.3
Reconstructed intra-op 0 0
Reconstructed pre-op 0 0
Covered, continued filling 4 25
Other 0 0
Inflow
Thoracic aorta 15 93.8
Graft 1 6.3
Outflow
Thoracic aorta 12 75
Graft 4 25
Supra-renal 0 0
Infrarenal 0 0
Mean  SD Range
Length of aortic coverage (cm) 28.5  8.5 20-45
Pre-op MAP (mm Hg) 100.6  20.8 70-152
Post-op MAP (mm Hg) 89.5  27.5 65-118
MAP, Mean arterial pressure; SCI, spinal cord ischemia; TEVAR, thoracic ehas also been shown to be significant in predicting SCI,1 lut this observation could not be confirmed in our study
ince continuous MAPs were not recorded intraoperatively
r postoperatively in a sufficient number of patients. While
emale gender has also been recognized as a risk factor for
CI,17 our study did not discern a relationship with gender
nd SCI (P .452). The only significant patient factor was
prior history of stroke (31.3% SCI vs 12% non-SCI; P 
044). This could be coincidental, as other reports note an
ncreased risk for postoperative stroke following TEVAR
ut lack an association between prior stroke and SCI.18
Lumbar spinal drainage is used to treat SCI by improv-
ng spinal cord perfusion via decreasing intrathecal pressure
y removal of cerebrospinal. Lumbar drains are placed
ither as a prophylactic measure or in response to neuro-
ts developing postoperative SCI and those without SCI
Non-SCI Total
n % P n %
.808
139 55.6 147 55.3
71 28.4 76 28.6
34 13.6 37 13.9
4 1.6 4 1.5
2 0.8 2 0.8
.026
26 10.4 32 12
20 8 21 7.9
34 13.6 37 13.9
6 2.4 6 2.3
9 3.6 10 3.8
10 4 11 4.1
145 58 149 56
.291
158 63.2 166 62.4
92 36.8 100 37.6
.520
172 68.8 183 68.8
1 0.4 1 0.4
26 10.4 27 10.2
2 0.8 2 0.8
18 7.2 18 6.8
26 10.4 30 11.3
5 2 5 1.9
.762
229 91.6 244 91.7
21 8.4 22 8.3
.123
205 82 217 81.6
20 8 24 9
21 8.4 21 7.9
4 1.6 4 1.5
ean  SD Range P Mean  SD Range
3.1  10.1 4-63 .036 23.4  10.0 4-63
8.4  26.7 31-183 .104 93.3  18.5 31-183
5.7  28.6 41-156 .215 95.3  18.6 41-156
scular aneurysm repair.atien
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January 20126 Keith et allumbar drainage with open TAAA repair have been de-
scribed, there is no consensus regarding use of lumbar
drainage for TEVAR. Multiple reports of lumbar drainage
for TEVAR have shown successful relief of neurologic
deficiencies associated with SCI.4,7,9,10 In our study, neu-
rologic changes associated with SCI occurred after 6.0% of
TEVARs. Our protocol called for increasing MAP in all
patients with neurologic change and immediate selective
postoperative drainage only if significant neurologic symp-
toms of SCI develop. With a selective approach, 10 of 16
Table III. Comparison of outcomes between patients dev
TEVAR (n  266)
SCI Non-SCI
n %
Graft Patency
Primary 15 93.8
Assisted 1 6.3
Occluded 0 0
Disposition
Home 6 37.5
Rehabilitation 6 37.5
Deceased 3 18.8
Re-operation during stay 1 6.3
Transfer 0 0
30-day mortality
3 18.8
1-year mortality
9 56.3
Mean  SD Range M
Post-op hospital days 18.6  21.9 1-85 10
SCI, Spinal cord ischemia; TEVAR, thoracic endovascular aneurysm repair.
Table IV. Comparison of patients developing SCI post-
TEVAR SCI between those requiring lumbar drain and
those without (n  16)
Drained Not drained P
Total
10 6
Resolution .240
Complete 3 4
Partial 4 0
None 3 2
Time of symptom onset .724
Mean (h) 35.7 29.5
Disposition .051
Home 2 4
Rehabilitation 6 0
Deceased 1 2
Additional intervention during
admission
1 0
30-day mortality .869
2 1
1-year mortality .302
7 2
SCI, Spinal cord ischemia; TEVAR, thoracic endovascular aneurysm repair.(62.5%) SCI patients required postoperative placement of a wumbar drain, and 7 of 10 (70%) drained patients achieved
ome degree of symptom resolution: 3 complete (30%) and
partial (40%). In contrast, symptoms in four of the six
66.7%) SCI patients who did not receive drainage com-
letely resolved, while the other two had no improvement.
he time to drain implementation from the onset of neu-
ologic symptoms wasmarginally significant in determining
egree of symptom resolution.
Others propose prophylactic lumbar drainage in pa-
ients with risk factors such as abdominal aortic aneurysm
AAA), previous AAA repair, or extensive aortic dis-
ase.11,19 However, routine prophylactic spinal drainage
as not consistently proven to reduce incidence of SCI,
ith reported SCI rates up to 6.6%.11,19 Furthermore,
otential complications of drainage include meningitis,
ntracranial hemorrhage, nerve injury with lumbar drain
nsertion, and subdural or epidural hematoma, as was ob-
erved in one of our lumbar drained patients.15,20-22 Rou-
ine lumbar drainage also complicates postoperative man-
gement with need for continuous ICU monitoring and
ecumbent positioning to avoid subdural bleeding and
xcessive drainage. While existence of infrarenal aortic pa-
hology (P  .026) was significantly related to subsequent
CI in our study, prophylactic lumbar drain placement in
ll patients with infrarenal aortic pathology would have led
o an additional 105 unnecessary lumbar drains in patients
ho did not develop SCI. In turn, these patients would
ave required extended ICU monitoring and prolonged
ospital stay, as well as added potential risk of complica-
ions from lumbar drainage.
Overall, the outcomes in our study emphasize the
mportance of not only effectively treating SCI once it
ccurs, but avoiding SCI altogether. The rate of mortality
ing postoperative SCI and those without SCI after
Non-SCI Total
% P n %
.726
87.6 234 88
10.4 27 10.2
2 5 1.9
.006
75.2 194 72.9
16.8 48 18
6.8 20 7.5
0.8 3 1.1
0.4 1 0.4
.072
5.6 17 6.4
.003
20.4 60 22.6
SD Range P Mean  SD Range
16.1 0-165 .056 11  16.5 0-165elop
n
219
26
5
188
42
17
2
1
14
51
ean 
.5 ithin 1 year of TEVAR was significantly higher for pa-
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Volume 55, Number 1 Keith et al 7tients who developed SCI postoperatively than those with-
out the complication (56.3% vs 20.4%; P  .003). If SCI
does occur, effective treatment leading to complete neuro-
logic recovery proves to increase 1-year survival. All of our
patients achieving complete recovery survived, while all
with partial or no recovery died within one year.
Considering all of the described methods for prevent-
ing and treating SCI in TEVAR patients, an optimal strat-
egy would be one that consistently prevents SCI. Current
data suggests that although some centers have had success
with various prophylactic approaches, there is no such
optimal strategy to date. Until a consensus prophylactic
protocol is developed, efforts must be directed towards
rapid symptom resolution. In our experience, the degree of
resolution using a selective lumbar drainage protocol was
acceptable, but it may be improved by more rapid identifi-
cation of neurologic change and protocol implementation.
The time to initiate drainage following symptom onset
varied marginally between resolution groups in our study,
suggesting that increased frequency of neurologic assess-
ments for patients deemed at high risk of developing SCI
should supplement our current protocol. By this adden-
dum, the patients most likely to experience SCI will be
monitored more intensively, and this will likely minimize
the time from symptom onset to drain placement if SCI
should develop.
Our study is not without deficiencies. First, there are
some factors that may be causative for SCI that our study
did not assess. For instance, MAP was not continuously
recorded in our patients, especially outside of the ICU.
One patient developed SCI following discharge, and while
there is no documented hypotension during his hospital-
ization, we do not have complete hemodynamic data fol-
lowing discharge. Second, there is a lack of operative details
such as periods of hypotension, embolization, coverage of
collaterals, and anticoagulation status that may have af-
fected clinical outcome. Third, not all patients received
formal neurologic evaluation or an MRI postoperatively,
and some patients may have had subtle weakness that was
attributed to the operative incision or femoral access site
that could have been low-grade SCI. Finally, considering
our limited patient population, conclusive analysis of SCI
risk factors and lumbar drainage strategies may require the
collaboration of multiple centers to pool data for more
definitive conclusions.
CONCLUSION
Spinal cord ischemia is a devastating complication that
may present following TEVAR. Because patients who ex-
perience SCI prove to have diminished 1-year survival
compared with patients without such SCI, an optimal
strategy would be one which consistently and effectively
reduces the incidence of SCI following TEVAR. Until such
an approach is supported by consensus, a protocol for
selective postoperative lumbar spinal drainage can be used
safely to achieve satisfactory neurologic resolution in pa-
tients experiencing SCI after TEVAR.UTHOR CONTRIBUTIONS
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third question relates to the pharmacological therapy in patients
who developed spinal cord ischemia. There is literature to support
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The kind of wait-and-see approach advocated in the accompanying
article1 works best if corrective measures can be initiated within
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Dr Peter H. Lin (Houston, Tex). The authors from the
University of Alabama should be congratulated on an excellent
study regarding the use of lumbar spinal drainage following tho-
racic endograft placement. Considering the presenting author is a
second-year medical student as well as an aspiring future vascular
surgeon, he should also be congratulated on a well-presented
study. In this report, the authors described their institutional
protocol regarding selective usage of lumbar drain in patients who
developed postoperative spinal cord ischemia following thoracic
aortic endograft placement. The authors reported several risk
factors which were associated with increased post-TEVAR spinal
cord ischemia, which included prior infrarenal aortic pathology,
length of thoracic aortic endograft coverage, and history of stroke.
I have three questions for the authors. First, given the study
findings which showed risk factors such as prior infrarenal aortic
pathology, long length of thoracic aortic endograft coverage, and
history of stroke were associated with increased spinal cord isch-
emia, have these findings changed your treatment approach when
encountering patients with these risk factors? Would you recom-
mend routine or prophylactic spinal drainage prior to thoracic
endograft placement in these patients, or would you advocate
selective spinal drain as mentioned in your protocol? My second
question is a clinical scenario. Considering the study finding which
showed patients with prior infrarenal aortic pathology who un-
dergo thoracic endovascular repair have higher risk of spinal cord
ischemia, what would be your treatment approach when encoun-
tering a patient with concomitant infrarenal aortic aneurysm and
thoracic aortic aneurysm in which both aneurysms have similar
size? Would you recommend staged endovascular treatment? If so,
which one would you approach first? Or would you perform a
combined endovascular treatment with spinal drain placement?Myhe use of steroids in these patients as a means to reduce swelling
nd spinal cord edema. Your study protocol did not include the use
f steroids in patients who develop spinal cord ischemia. Can you
hare your thoughts as to why this was not included in your
harmacological treatment protocol in patients with spinal cord
schemia?
Once again, the authors should be congratulated on an excel-
ent study. I thank the authors for providingme with a well-written
anuscript in a timely fashion and I also thank the association for
he privilege of discussing this paper.
Dr Charles J. Keith, Jr. Thank you, Dr Lin, for your com-
ents and questions. First, I would like to address your question
bout the prophylactic drainage. The use of prophylactic drainage
as been advocated in some studies and literature; however, if we
ad deployed prophylactic lumbar drain in all patients with infra-
enal pathology we would have deployed an additional and unnec-
ssary 105 drains. These drains would have required increased
onitoring, an increased length of stay, and increased cost. You
lso cannot neglect the certain risks that come along with drainage,
n particular an epidural hematoma, as was experienced by one of
ur patients. Secondly, in regards to your clinical scenario about
eparate abdominal and thoracic aneurysms, clinical decisions
ould be based on themerits of each aneurysm separately based on
ize thresholds and anatomic constraints. Certainly, we would
refer a staged approach if appropriate with choice of which
neurysm to approach first based on weighing several of these
actors, reserving selective lumbar drainage for those that develop
eurologic symptoms. Finally, I would like to address your ques-
ion about the role of steroids. We did not include steroids in our
rotocol. Our neurosurgeons who had input into developing and
arrying out this protocol do not support steroid use, but in some
ettings it may be something to consider.INVITED COMMENTARYTimothy A. M. Chuter, MD, San Francisco, Calif
Although endovascular techniques avoid some intraoperative
causes of spinal ischemia, such as aortic cross-clamp and hemody-
namic instability, thoracic aortic exclusion inevitably occludes all
the intercostal arteries within the field of the repair, leaving seg-
ments of the spine dependent on collateral flow. The resulting
lower extremity weakness tends to be delayed, partial, and revers-
ible.Many large studies have shown routine spinal fluid drainage to
be a highly effective preventative measure following open surgical
repair of the thoracoabdominal1 and descending thoracic segments
of the aorta. The same appears to be true of endovascular repair.2-5
The metabolic effects of neuronal ischemia contribute to a
positive feedback loop that soon makes the process irreversible.inutes of symptom onset. A mean delay of 8 hours between
ymptom onset and cerebrospinal fluid drainage may explain why
nly 3/10 patients regained full lower extremity motor function.
n even longer delay of 19 hours in the three patients with
bsolutely no resolution of symptoms probably contributed to
heir poor outcome. Tomakematters worse, all seven patients with
esidual lower extremity weakness were dead within a year.
Routine spinal fluid drainage largely eliminates treatment
elays and has proven to be an effective means of preventing
araplegia.3 The benefits of this prophylactic measure vary with the
isk of paraplegia. The overall rate (6%) of lower extremity weak-
ess reported in the accompanying article is fairly typical and one
ight argue, as the authors do, that routine spinal drainage of
very patient undergoing endovascular thoracic aortic repair is
